{"id":134,"date":"2016-10-08T07:17:25","date_gmt":"2016-10-08T14:17:25","guid":{"rendered":"http:\/\/pictureyourselfin.com\/blog\/?p=134"},"modified":"2017-09-17T07:20:10","modified_gmt":"2017-09-17T14:20:10","slug":"free-fda-online-program-about-fdas-role-in-public-health-drug-efficacy-safety-quality-and-beyond","status":"publish","type":"post","link":"https:\/\/pictureyourselfin.com\/blog\/2016\/10\/08\/free-fda-online-program-about-fdas-role-in-public-health-drug-efficacy-safety-quality-and-beyond\/","title":{"rendered":"Free FDA Online Program about FDA’s Role in Public Health – Drug Efficacy, Safety, Quality, and Beyond"},"content":{"rendered":"
\"Free
Free FDA Online Program about FDA’s Role in Public Health<\/figcaption><\/figure>\n

The FDA is offering a free online class “FDA’s Role in Public Health: Drug Efficacy, Safety, Quality, and Beyond” available at http:\/\/fdadrugregulations.e-paga.com\/<\/a><\/p>\n

Here is more information from their website about it:<\/p>\n

This activity is supported by the US Food and Drug Administration (FDA) through a contract from the Department of Health and Human Services, and FDA’s privacy policies apply while you are on this site.
\nContinuing Education Credits (CE) Released: 2\/25\/2016; Valid for credit through: 2\/24\/2019
\nCredits Available:<\/p>\n

Physicians \u2013 1.5 AMA PRA Category 1 Credit(s)\u2122
\nNurses \u2013 1.5 ANCC Contact Hours
\nPharmacists \u2013 1.5 ACPE Contact Hours
\nNurse Practitioners \u2013 1.5 AANP Contact Hours
\nPhysician Assistants \u2013 1.5 hours of Category I Credit
\nCertificates of Completion:<\/p>\n

For users wishing to have confirmation that they have completed this course, they may choose to receive a Certificate of Completion which comes with no CE credits.
\nTarget Audience:<\/p>\n

\"Free
Free FDA Online Program about FDA’s Role in Public Health<\/figcaption><\/figure>\n

The target audience for this course is healthcare professionals, including physicians, physician assistants, nurses, nurse practitioners, and pharmacists. The course can be taken for informational purposes or for Continuing Education (CE) credit.
\nDescription:<\/p>\n

This activity explains how U.S. public health policy has influenced and shaped the Food and Drug Administration (FDA) protections that Americans have come to expect, provides an overview of FDA\u2019s Center for Drug Evaluation and Research, or CDER\u2019s, role in the regulation of new drug development, marketed drugs, quality testing, and post-market surveillance, and identifies new directions for the human drug regulatory process in the United States.<\/p>\n

Learning Objectives: Upon completion of this activity, participants should be able to:<\/p>\n

    \n
  1. Describe and explain the drug development and review process in the United States for new drugs, generics, over-the-counter (OTC) drugs, and biosimilars<\/li>\n
  2. Outline CDER\u2019s role in post-marketing safety surveillance for medical products<\/li>\n
  3. Identify ways CDER disseminates safety information about medical products to both health care professionals and their<\/li>\n
  4. Describe CDER initiatives and commitments for the protection of public health<\/li>\n
  5. Describe the new drug development and review process<\/li>\n<\/ol>\n

     <\/p>\n

    Learn more about Careers in Clinical Research<\/a><\/p>\n

    <\/p>\n

     <\/p>\n

    \n
    \n
    \n

    Subscribe to our Clinical Research Newsletter!<\/h2>\n
    *<\/span> indicates required<\/div>\n